Towards Healthcare
Liver Disease Therapeutics Market to Reach USD 45.25 Bn by 2035

Liver Disease Therapeutics Market Evolves with Smart Biotech

According to market projections, the global liver disease therapeutics market, valued at USD 26.54 billion in 2025, is anticipated to reach USD 45.25 billion by 2035, growing at a CAGR of 5.48% over the next decade. The liver disease therapeutics market is growing due to rising research in novel therapeutics. North America is leading the market due to growing collaboration among key players.

Content

  • Last Updated: 12 November 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

The liver disease therapeutics market holds a valuation of USD 27.99 billion as of 2026, and will expand to USD 45.25 billion by 2035, achieving a CAGR of 5.48% between 2026 and 2035.

North America is currently leading the liver disease therapeutics market share by 40% due to rising cases of liver diseases due by the consumption of ultra-processed food.

The liver disease therapeutics market comprises six segments indication, therapy type mechanism, modality drug class, route of administration dosage form, end-user care setting, and region.

Some key players include AbbVie, Pfizer, Sanofi, Novartis, Roche, Merck & Co., etc.

The severity of your liver disease will determine how it is treated. Your doctor might suggest lifestyle modifications like quitting alcohol, avoiding over-the-counter pain relievers like acetaminophen, cutting back on fatty foods, and losing weight.

From a few weeks for minor problems like fatty liver to several months or more for more serious damage, the time it takes for the liver to heal varies greatly based on the extent of the damage.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC, GOV.UK.
Any Questions